Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengwei Tan

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Frontiers in Immunology|May 31, 2021
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell CarcinomaWei Guo, Fengwei Tan, Qilin Huai, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 19, 2020
Treatment outcomes of patients with tracheobronchial mucoepidermoid carcinoma compared with those with adenoid cystic carcinomaYalong Wang, Songhua Cai, Qi Xue, et al.
Journal of Thoracic Disease|November 17, 2022
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinomaChenguang Zhao, Shugeng Gao, Qi Xue, et al.
Journal of Thoracic Disease|July 10, 2020
Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysisXiangyang Yu, Shugeng Gao, Qi Xue, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 13, 2018
[Effect of Thoracic Surgeons on Lung Cancer Patients' Survival]Ning Li, Fengwei Tan, Bin Qiu, et al.
Cancer Biology & Therapy|March 9, 2011
DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancerZhen Wang, Zhaoli Chen, Yushun Gao, et al.
Journal of Cancer|July 11, 2019
Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinomaYibo Gao, Wei Guo, Songhua Cai, et al.
Frontiers in Immunology|February 28, 2022
Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive AnalysisMingchuang Zhu, Qingpeng Zeng, Tao Fan, et al.
Frontiers in Molecular Biosciences|March 29, 2021
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related BiomarkersSijin Sun, Wei Guo, Fang Lv, et al.
The Journal of Pathology|March 28, 2025
Multi-omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinomaYang Qu, Xiaoli Feng, Hanlin Chen, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Frontiers in Immunology|May 31, 2021
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell CarcinomaWei Guo, Fengwei Tan, Qilin Huai, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 19, 2020
Treatment outcomes of patients with tracheobronchial mucoepidermoid carcinoma compared with those with adenoid cystic carcinomaYalong Wang, Songhua Cai, Qi Xue, et al.
Journal of Thoracic Disease|November 17, 2022
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinomaChenguang Zhao, Shugeng Gao, Qi Xue, et al.
Journal of Thoracic Disease|July 10, 2020
Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysisXiangyang Yu, Shugeng Gao, Qi Xue, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 13, 2018
[Effect of Thoracic Surgeons on Lung Cancer Patients' Survival]Ning Li, Fengwei Tan, Bin Qiu, et al.
Cancer Biology & Therapy|March 9, 2011
DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancerZhen Wang, Zhaoli Chen, Yushun Gao, et al.
Journal of Cancer|July 11, 2019
Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinomaYibo Gao, Wei Guo, Songhua Cai, et al.
Frontiers in Immunology|February 28, 2022
Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive AnalysisMingchuang Zhu, Qingpeng Zeng, Tao Fan, et al.
Frontiers in Molecular Biosciences|March 29, 2021
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related BiomarkersSijin Sun, Wei Guo, Fang Lv, et al.
The Journal of Pathology|March 28, 2025
Multi-omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinomaYang Qu, Xiaoli Feng, Hanlin Chen, et al.
Pageof 16